Nathan Rice
Stock Analyst at Piper Sandler
(2.88)
# 1,849
Out of 5,090 analysts
60
Total ratings
50%
Success rate
8.33%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $39.85 | +20.45% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $34.39 | +22.13% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $29.19 | +19.90% | 9 | Oct 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $137 → $142 | $129.86 | +9.35% | 9 | Oct 23, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $75.63 | -2.16% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $129.69 | -35.23% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $157.21 | +25.31% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $21.90 | -58.90% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $714.10 | -39.08% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $265.44 | -12.22% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $38.34 | +116.48% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $19.62 | -23.55% | 1 | Dec 19, 2019 |
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $39.85
Upside: +20.45%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $34.39
Upside: +22.13%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $29.19
Upside: +19.90%
Bank First
Oct 23, 2025
Maintains: Neutral
Price Target: $137 → $142
Current: $129.86
Upside: +9.35%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $75.63
Upside: -2.16%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $129.69
Upside: -35.23%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $157.21
Upside: +25.31%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $21.90
Upside: -58.90%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $714.10
Upside: -39.08%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $265.44
Upside: -12.22%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $38.34
Upside: +116.48%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $19.62
Upside: -23.55%